Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Venus Remedies Share Price

Venus Remedies Ltd.

₹1,053.50

29.50(2.88%)

Trade Now

22nd Apr 2026 | 3:28 PM

NSE : VENUSREM

Open Free Demat Account

Venus Remedies Performance

Price Movement

₹1053.50

₹991.00

₹1059.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1053.50

₹294.15

₹1088.80

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,059.00

Low₹991.00

Open at₹1,038.00

Prev Close₹1,024.00

Volumes64.71 K

Avg Price₹1,019.46

Lower Circuit₹972.80

Upper Circuit₹1,075.20

Historical Performance

3M High₹1,088.80

3M Low₹622.10

1 Yr High₹1,088.80

1 Yr Low₹294.15

3 Yr High₹1,088.80

3 Yr Low₹188.60

5 Yr High₹1,088.80

5 Yr Low₹145.80

Venus Remedies Fundamentals

Market Cap

Above industry Median

1,368.80 Cr.

PE Ratio (TTM)

Below industry Median

17.90

Dividend Yield

Net Profit TTM

119.0% incr over last year

76.31

Net Profit Growth

119.0% incr over last year

76.31

PEG Ratio

Below industry Median

0.20

ROE

38.2% incr over last year

8.07

Operating Revenue TTM

699.88

Operating Revenue Growth

8.0% incr over last year

Book Value

Below industry Median

2.20

MFI

MFI Overbought

72.51

RSI

RSI is mid-range

65.48

EPS (TTM)

33.90

Debt to Equity

Face Value

Operating Profit Margin Qtr.

9.50

Operating Profit Qtr.

37.52

Net Profit Qtr.

25.58

Operating Revenue Qtr.

180.26

PB Ratio

2.20

Venus Remedies Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	179.95	192.65	131.85	194.04	172.54
Operating Expense	143.23	162.81	119.20	171.49	149.63
Operating Profit	36.72	29.84	12.65	22.55	22.91
Depreciation	6.32	5.92	5.95	4.49	5.20
Interest	0	0	0	0	0
Tax	7.89	6.36	3.01	10.04	5.28
Net Profit	24.92	19.24	11.69	14.79	24.08

Venus Remedies Technicals

Venus Remedies Ltd. EMA & SMA

₹1053.50

30.65 (3.00%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1026

Day EMA10 ₹997.5

Day EMA12 ₹986

Day EMA20 ₹946.8

Day EMA26 ₹923.7

Day EMA50 ₹862.2

Day EMA100 ₹780.9

Day EMA200 ₹670.5

Venus Remedies Support and Resistance

Resistance

First Resistance₹1063.45

Second Resistance₹1104.05

Third Resistance₹1130.10

Support

First Support₹996.80

Second Support₹970.75

Third Support₹930.15

Technical Indicators

Day RSI65.48

Day MFI72.51

Day ADX28.28

Day Commodity Channel Index100.40

William-24.50

Day MACD62.31

Day MACD Signal Line53.42

Day ATR51.39

Day ROC125126.24

Day ROC2112.19

Venus Remedies Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	41.8	41.8	41.8	41.8	41.8	41.8
FII	1.1	1.3	2.2	1.9	2.2	2.8
DII	0	0	0.2	0.7	1.1	1.2
Public	57.1	56.9	55.9	55.6	55	54.2

Venus Remedies Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	31.47 K	62.35 K	50.47%
Week	35.75 K	59.02 K	60.58%
1 Month	39.62 K	62.77 K	63.12%
6 Month	44.7 K	74.85 K	59.72%

Venus Remedies SWOT Analysis

Strengths41

Weakness3

Opportunity1

Threats0

High DVM Mid and Small Caps (subscription)

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Undervalued Growth Stocks

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

DVM Performers for All Stocks (weekly, higher risk) - subscription

Relative Outperformance versus Industry over 1 Month

High DVM Midcap Stocks (MarketCap 1000-10,000)

Momentum Play Screener - Weekly Screener

Relative Outperformance versus Industry over 1 Year

Affordable stocks with good momentum and ROE - All Stocks (subscription)

Companies with high TTM EPS Growth

Stringent DVM Screener

Combined DVM and Piotroski Scores Screener (subscription)

Weekly Screener: High Momentum Score Stocks (subscription)

Higher DVM Stocks Among Midcaps and Largecaps

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Companies with rising net profit margins - quarterly as well as TTM basis

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Highest Recovery from 52 Week Low

RSI indicating price strength

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Venus Remedies Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
23 Sep, 2013	3	FINAL		Equity Share
20 Sep, 2012	3	FINAL		Equity Share
22 Sep, 2011	3	FINAL		Equity Share
23 Sep, 2010	3	FINAL		Equity Share
17 Sep, 2009	3	FINAL		Equity Share
12 Sep, 2008	4	FINAL		Equity Share
18 Sep, 2007	3	FINAL		Equity Share
21 Sep, 2006	2	FINAL		Equity Share
03 Feb, 2005	1	INTERIM	04 Feb, 2005	Equity Share

Venus Remedies Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Senores Pharmaceuticals Ltd.
Price (₹)	₹489	₹6.89	₹135.30	₹145.49	₹570.35	₹880.10
% Change	1.50%	-4.97%	-1.28%	2.20%	0.47%	-1.74%
Revenue TTM (₹ Cr)	-	₹83.60	₹282.74	-	₹488.20	₹588.52
Net Profit TTM (₹ Cr)	-	₹-34.95	₹15.30	-	₹56.90	₹101.60
PE TTM	-	-1.70	34.80	-	28.80	40.60
1 Year Return	22.9	625	8.78	56.44	-15.67	63
ROCE	28.91	-5.63	-	-	23.87	9.34

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 706.00

-2.44%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 68.00

-0.13%

SUPRIYA

Supriya Lifescience Ltd.

₹ 657.10

+5.86%

SIGACHI

Sigachi Industries Ltd.

₹ 22.95

+2.41%

WINDLAS

Windlas Biotech Ltd.

₹ 884.80

+0.14%

VINEETLAB

Vineet Laboratories Ltd.

₹ 40.05

+2.14%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 493.00

+2.06%

ZIMLAB

Zim Laboratories Ltd.

₹ 87.53

+3.93%

MEDICO

Medico Remedies Ltd.

₹ 42.50

+3.61%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 170.00

+0.26%

LASA

Lasa Supergenerics Ltd.

₹ 8.75

+0.23%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 300.00

+0.79%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 333.10

+1.38%

ORTINGLOBE

Ortin Global Ltd.

₹ 14.40

-3.03%

BROOKS

Brooks Laboratories Ltd.

₹ 61.05

-4.67%

RPGLIFE

RPG Life Sciences Ltd.

₹ 1964.70

-1.70%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 133.20

-2.38%

ALPA

Alpa Laboratories Ltd.

₹ 69.00

+0.31%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 143.68

-0.26%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 421.45

+3.27%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.35

+1.48%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 28.20

-1.81%

INDOCO

Indoco Remedies Ltd.

₹ 215.00

+0.84%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 142.50

-1.00%

FAQ's on VENUSREM

What is the current share price of Venus Remedies Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Venus Remedies Ltd. is ₹ 1053.5 on the NSE and ₹ 1050.7 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Venus Remedies Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Venus Remedies Ltd. is approximately ₹ 1368.8 Cr.

What are the PE and PB ratios for Venus Remedies Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Venus Remedies Ltd. is 17.9, and the Price-to-Book (PB) ratio is 2.2.

What is the 52-Week High and Low for Venus Remedies Ltd.?

Over the past 52 weeks, the highest price reached by Venus Remedies Ltd. shares was ₹ 1088.8, and the lowest price was ₹ 294.15.

Who are the major shareholders of Venus Remedies Ltd.?

Significant shareholdings in Venus Remedies Ltd. typically include entities such as:

Public
Promoter
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Venus Remedies Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Venus Remedies Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

What is the latest dividend information for Venus Remedies Ltd.?

Venus Remedies Ltd. last declared a FINAL dividend of ₹ 3 per share for the financial period ending 2013. The record date was set as 2013-09-23, and the payment was/is scheduled around 2013-09-23. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy